Consider investing in Charles River Laboratories (CRL) as a dominant picks-and-shovels play, given its near-monopoly position in essential pre-clinical drug testing for roughly 80% of all brought-to-market drugs. Capitalize on the broader Artificial Intelligence & Tech-Enabled Services sector by targeting niche vertical SaaS companies that automate overlooked, low-tech industries. Focus specifically on B2B software providers modernizing medical and dental practice back-offices, such as Daydream Dental, which successfully recapture 15% to 20% in lost revenue through workflow automation. Seek out small and medium-sized business software solutions that solve high-friction operational pain points, as these businesses typically exhibit strong pricing power and high customer retention.

Charles River Laboratories (CRL)

• The company is a publicly traded business based in Boston that provides research and testing services as a service for biotech companies.
• Charles River Labs works with roughly 80% of biotech companies and approximately 80% of drugs that go to market are tested through them, giving them an absolute monopoly-like position with around $4 billion in annual revenue.
• They handle testing using mice, rats, dogs, and monkeys (non-human primates), and they even purchased a monkey breeding business for $500 million to better control their supply chain against wild price swings and supply shocks.
• Non-human primates like long-tailed macaques are critical for late-stage pre-clinical drug testing before human trials, with costs per monkey historically surging from thousands to tens of thousands of dollars during supply shortages (such as when China halted exports).

Takeaways

• Charles River Laboratories operates as a critical, high-moat infrastructure provider within the broader biotechnology and pharmaceutical sector.
• Investors looking for picks-and-shovels plays in healthcare may find value in companies that command massive market share in essential regulatory testing pipelines.

Artificial Intelligence & Tech-Enabled Services (Sector Theme)

• The podcast discussed specialized tech-enabled service businesses that disrupt traditional, low-tech industries by automating complex back-office workflows.
• One specific example highlighted is dental practice back-offices (such as Daydream Dental), which use software and automation to handle insurance claims, billing codes, and patient verifications, ultimately reclaiming 15% to 20% in lost revenue for dental practices.
• These niche B2B software and service companies often fly under the radar of traditional high-tech venture capital, allowing them to scale rapidly in uncrowded competitive landscapes.

Takeaways

• Look for investment themes centered around vertical SaaS (Software as a Service) and AI-driven automation applied to traditional, unsexy service industries (like healthcare back-offices, dental practices, and industrial maintenance).
• Companies solving specific, high-friction operational pain points for small and medium-sized businesses often boast high customer retention and strong pricing power.